EnsoData

We started EnsoData in 2015 to provide diagnoses for health conditions using Artificial Intelligence (AI) and Machine Learning (ML), primarily in sleep medicine. Our main product, EnsoSleep, received FDA clearance in 2017 for analyzing in-lab sleep studies. In 2021, the FDA expanded its clearance to include home sleep studies, allowing us to score and analyze these studies, measure total sleep time, and offer a platform for viewing, editing, and reporting. Most recently, in February 2024, our EnsoSleep PPG algorithm received FDA clearance for AI-driven analysis using pulse oximetry technology. We also offer EnsoHST. Our AI tools help reduce healthcare turnaround times, manage patient backlogs, and improve patient care and health outcomes. Our work in the healthcare industry leverages Machine Learning, Big Data, Cloud Computing, Signal Processing, and Artificial Intelligence.

Our mission is to provide faster, more accurate, and affordable diagnoses, ultimately improving patient care and health outcomes. We believe our AI-driven solutions can make healthcare more effective and accessible. We foster a collaborative culture where we prioritize quality and integrity.

EnsoData has 51-200 employees. The work environment supports both hybrid and remote arrangements, with an optional office available in Madison, WI. The culture is collaborative, fast-paced, and committed to quality and integrity, focusing on using healthcare technology to improve patient outcomes.

We offer a flexible work environment with remote and hybrid options, including access to an optional office in Madison, WI. Our benefits include health, dental, and vision insurance (with various plan options), paid time off, parental and caregiver leave, stock options, a company bonus program, and a 401k retirement plan. We also organize team summits and in-person gatherings.